QuidelOrtho is engaged in the development, manufacturing and marketing of diagnostic testing solutions. Co.'s diagnostic testing solutions are separated into its four product categories: rapid immunoassay, cardiometabolic immunoassay, molecular diagnostic solutions and specialized diagnostic solutions. Co.'s products are used in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers, as well as for individual, non-professional, over the counter use. Co. markets its products through a network of distributors and a direct sales force. We show 59 historical shares outstanding datapoints in our coverage of QDEL's shares outstanding history.
Understanding the changing numbers of QDEL shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like QDEL versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching QDEL by allowing them to research QDEL shares outstanding history
as well as any other stock in our coverage universe. |
Free QDEL Email Alerts:
Video: Shares Outstanding Importance
